Cite

HARVARD Citation

    Al-Saffar, N. et al. (2018). Metabolic biomarkers of response to the AKT inhibitor MK-2206 in pre-clinical models of human colorectal and prostate carcinoma. British journal of cancer. 119 (9), pp. 1118-1128. [Online]. 
  
Back to record